ARLO TECHNOLOGIES, INC.

ARLO

CIK 0001736946 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$141M
↑+16.2% +$20Mvs FY2024 (Q4)
Operating Income
$5M
↓-83.6% -$24Mvs FY2024 (Q4)
Net Income
$3M
↓-88.7% -$24Mvs FY2024 (Q4)
Gross Profit
$66M
↑+46.1% +$21Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
54/100
  • Profitability
    0ROIC 5.1% (10% = solid, 20%+ = moat)
  • Liquidity
    51Current Ratio 1.51 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    100Asset Turnover 1.74x (1.0+ = capital-efficient)
  • Growth
    71Revenue YoY +16.2% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 3.3% · trend +8.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ARLO's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$12.29
Total enterprise IV
$1.35B
Diluted shares
0.11B
Terminal PV
$982M (72% of total)
Year-5 FCF
$116M
YearProjected FCFDiscounted PV
+1$85M$77M
+2$92M$76M
+3$99M$75M
+4$107M$73M
+5$116M$72M
Terminal$1.58B$982M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$3M
investment in PP&E
Stock buybacks (TTM)
$46M
share count reduction
Stock-based comp (TTM)
$62M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$311M
everything owned
Total liabilities
$183M
everything owed
Stockholders' equity
$128M
shareholder claim

Recent performance · 37 quarters

Revenue↑+16.2% +$20M
$141M
Net Income
$6M
Free Cash Flow↑+253.3% +$14M
$20M
Operating Margin
3.3%

Drill down